Dissolution: A continuing perspective

Dissolution Technologies

Volumn 11, Issue 3, 2004, Pages 6-7

  Williams, Roger L ^a   Foster, Thomas S ^b  

^a Council of Experts ^*  (United States)

^b UNITED STATES PHARMACOPEIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACT; BIOEQUIVALENCE; CALIBRATION; CALIBRATOR; CONTINUOUS PERFORMANCE TEST; DISSOLUTION; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG QUALITY; FOOD AND DRUG ADMINISTRATION; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPOTHESIS; IN VITRO STUDY; MEDICAL LITERATURE; NOTE; PERFORMANCE; QUALITY CONTROL; RISK ASSESSMENT; TABLET DISINTEGRATION; WORLD HEALTH ORGANIZATION;

EID: 84962115440     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT110304P6     Document Type: Note

References (3)

1. Shah VP, Williams RL: Role of Dissolution Testing in Regulating Pharmaceuticals, Dissolution Technologies, 1999 6(3), 7.
2. Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability (WHO Expert Committee on Specifications for Pharmaceutical Preparations, Thirty- Fourth Report, 1999)
3. Guidance on the selection of comparator pharmaceutical products for equivalence assessment of interchangeable multisource (generic) products, WHO Expert Committee on Specifications for Pharmaceutical Preparations, Thirty-Sixth Report, 1999.